AzTrials
AzTrials

Total Shoulder ArthroplastyPhase 4NCT07721415

Iodine Drapes Used in TSA

A Phase 4 study testing Total shoulder arthroplasty, Iodine impregnated drapes and Tissue Culture Samples in people with Total Shoulder Arthroplasty and Iodine, run by tnicholson at 1 site in United States.

Enrolling by invitation

Enrolling by invitation. The study team selects and invites participants, usually from an existing group of patients.

Sites and contacts
Official record
Search all trials

Trial summary

This study will directly compare the positive culture rate in shoulder arthroplasty using iodine-impregnated versus non-iodine-impregnated drapes used during surgery Read more about this study

Who is it for?
Ages 18 years and older, men onlyHealthy volunteers can take part
What is being tested?
Total shoulder arthroplasty, Iodine impregnated drapes and Tissue Culture Samples
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
128 participants
Where
1 siteUnited States
Study dates
5 Jan 2026to 31 Dec 2029
Phase
Phase 4
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Men only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Adults ≥ 18 years
  • Written informed consent
  • Elective primary total shoulder arthroplasty
  • Male patients

Who cannot join

  • Prior surgery on the operative shoulder
  • Iodine allergy
  • Participation in other clinical trials
  • Active infection

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

United States1 site
  • Rothman Orthopaedic Institute

    Philadelphia, Pennsylvania, 19107

Other trials in United States

About this study

Official title: Effect of Iodine Impregnated Drapes on the Rate of Positive Cultures in Primary Total Shoulder Arthroplasty - a Prospective, Randomized Study

This study will directly compare the positive culture rate in shoulder arthroplasty using iodine-impregnated versus non-iodine-impregnated drapes used during surgery

Being tested
Total shoulder arthroplasty, Iodine impregnated drapes, Tissue Culture Samples

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Total shoulder arthroplastyProcedure or surgery

    Participant will have total shoulder arthroplasty surgery

  • Iodine impregnated drapesDrug

    After cleaning the shoulder area in preparation for surgery, the area will be covered and draped using iodine impregnated drapes prior to the start of the participants surgery.

  • Tissue Culture SamplesProcedure or surgery

    One deep tissue swab will be taken after final shoulder implant placement and sent for culture to see if bacteria grows after surgery.

Study groups in NCT07721415
Study groupRoleWhat they receive
Iodine DrapesActive comparatorWhen the participant is in the operating room Surgical draping will be performed using cloth drapes impregnated with iodine
Receives: Procedure: Total shoulder arthroplasty; Drug: Iodine impregnated drapes; Procedure: Tissue Culture Samples
Non-iodine drapesActive comparatorWhen the participant is in the operating room Surgical draping will be performed using standard cloth drapes
Receives: Procedure: Total shoulder arthroplasty; Procedure: Tissue Culture Samples

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Culture positivity rate

    One deep tissue swab will be taken after final implant placement and sent for culture to see if bacteria grows after surgery.

    Measured: 13 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Jul 2026
  2. Study start5 Jan 2026
  3. Primary completion31 Dec 2029 (estimated)
  4. Study completion31 Dec 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
128 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07721415
Sponsor's protocol ID
SNAM20251199
Status last verified
Jul 2026
First submitted
29 Dec 2025
Last updated
23 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
Yes
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing Total shoulder arthroplasty, Iodine impregnated drapes and Tissue Culture Samples in people with Total Shoulder Arthroplasty and Iodine, run by tnicholson at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: enrolling by invitation, as of the sponsor's last update on 23 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Culture positivity rate (time frame: 13 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jul 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in